Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Xinping Cao(Tianjin Medical University), Mingfeng Zhao(Nankai University), Xin Jin(Central South University), Ruiting Guo(Tianjin Medical University), Yi Zhang(Tianjin Medical University General Hospital), Paudel Utsav(Tianjin Medical University), Xiaomei Zhang(Tang Hospital), Wenyi Lu(Tianjin First Center Hospital)
Cited by 25
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k